# ASBMR Three Year Pre-Meeting Symposia

> **NIH NIH R13** · AMERICAN SOCIETY FOR BONE & MINERAL RES · 2022 · $43,000

## Abstract

The American Society for Bone and Mineral Research (ASBMR), the largest professional, scientific and medical
society established to bring together clinical and laboratory-based scientists who are involved in the study of
bone, mineral and musculoskeletal science, has had a successful history of conducting annual topical meetings
funded by single year NIH R13 grants since 2002. More recently, ASBMR received two, three-year R13 grants
to cover pre-meeting symposia programs for 2016-2018 and 2019-2021. The current application seeks funding
for a three-year R13 grant to advance the field of musculoskeletal diseases by focusing on three specific areas
of scientific research in 2022, 2023 and 2024: 1) “Rare Diseases: From Molecules and Mechanisms to
Therapeutics”; 2) “Osteocytes in Bone Health and Disease and as Therapeutic Target Cells”; 3) “Energy
Metabolism in Skeletal Development and Disease”. These three symposia cover highly relevant areas of
musculoskeletal research that has recently undergone rapid evolution in scientific knowledge and collectively
contribute to major clinical morbidity disability and mortality. The overall objective of this R13 is to stimulate
further advances that will result in improved patient care for musculoskeletal diseases by bringing together the
best researchers for each of the three symposia. The symposia will review the state of the art in each topic area,
exchanging ideas with attendees, and stimulating the interaction between young and established researchers.
Symposia attendees will be encouraged to attend the subsequent ASBMR Annual Meetings for additional
opportunities to interact with musculoskeletal researchers. Programs for all three symposia were developed by
an organizing committee, and all speakers for the first two symposia have confirmed their participation.
Presenters include established and young investigators, women and men, and, since about half of ASBMR
membership is from outside the US, a number of key international speakers have also been invited. Poster
sessions, young investigator award presentations, and at the end of each meeting a “dine-around” evening are
planned to promote direct interaction between young investigators and more senior speakers. In 2022, the
symposium will gather international experts in rare bone diseases to discuss the latest advances on underlying
mechanisms and therapies, provide guidance to clinicians on how to recognize them, and lessons learnt from
rare diseases that have direct application to more common bone diseases such as osteoporosis. In 2023, the
symposium will review the advances in basic, translational and clinical research on the role of osteocytes in the
biology and pathophysiology of bone, and how to target osteocytes with therapeutic goals. The osteocyte role in
mechanobiology, hormone actions, cancer in bone and osteocyte endocrine actions will be discussed. The 2024
symposium will discuss the recent advances on the role of energy metabolism in skeletal...

## Key facts

- **NIH application ID:** 10468525
- **Project number:** 1R13AR081110-01
- **Recipient organization:** AMERICAN SOCIETY FOR BONE & MINERAL RES
- **Principal Investigator:** Teresita M. Bellido
- **Activity code:** R13 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $43,000
- **Award type:** 1
- **Project period:** 2022-06-01 → 2025-05-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10468525

## Citation

> US National Institutes of Health, RePORTER application 10468525, ASBMR Three Year Pre-Meeting Symposia (1R13AR081110-01). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10468525. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*